Recombinant Apolipoprotein C1 (APOC1)
Cat#:TP01195应用:Positive Control; Immunogen; SDS-PAGE; WB
Product Name: | Apolipoprotein CI Rabbit pAb |
Cat No.: | DPA03097 |
Clonality: | Polyclonal |
Species Reactivity: | Human |
Tested Applications: | WB,IHC,ICC/IF,FC,IP |
Recommended Dilution: | WB: 1:1000 IHC: 1:100 ICC/IF: 1:200 FC: 1:20 IP: 1:20 |
Size: | 30ul 50ul 100uL |
Format: | Liquid |
Source: | Rabbit |
Purification Method: | Affinity Purification |
Isotype: | IgG |
Conjugate: | Un-conjugated |
Storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a |
Immunogen: | Recombinant protein of human Apolipoprotein CI |
Calculated Molecular Weight: | 9 kDa |
Observed Molecular Weight: | 6 kDa |
GenBank Accession Number: | P02654 |
Gene ID (NCBI): | 341 |
Synonyms: | Apo-CI; ApoC-I; apo-CIB; apoC-IB |
Background: | This gene encodes a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. The encoded protein plays a central role in high density lipoprotein (HDL) and very low density lipoprotein (VLDL) metabolism. This protein has also been shown to inhibit cholesteryl ester transfer protein in plasma. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Sep 2016] |
Category: | Primary Ab |